Rebirth of the God-level Xueba

"The Li family is lucky, and they survived this time." Hu Chi disappeared for a few days, and when he reappeared, he looked like he had survived the catastrophe.

Yang Rui wanted to laugh when he heard that, slowly brewing tea, he said: "Winter is the hardest for old chronic bronchitis patients, but as long as they get through it, it will be regarded as another year."

"Yes, the coldest time has passed, and there should be no more accidents." Hu Chi drank tea, praised him, and said, "Can't the cost of making medicine be lowered?" ? This year has passed and there will be next year."

After Mr. Li, there is Mr. Wang. If this is the case, Comrade Hu Chi naturally needless to say it.

Yang Rui said indifferently: "Yes, there are expensive ways, and there are poor ways."

He is not perfunctory. Regardless of the lack of new drug development in China, on the one hand, there are huge risks; on the other hand, the laws and regulations are relatively backward, and there is no motivation to develop new drugs.

Most enterprises, after all, have to face the local market and the domestic market.

For Chinese companies, the primary goal of research and development is to solve the problem of domestic drug use. Domestic medical policies are far less complex and demanding than those in Europe and the United States.

For the same clinical trial, all the steps can be omitted in China. Traditional Chinese medicines and proprietary Chinese medicines don’t even need to be double-blind, so there is no need for clinical trials.

In this context, domestic companies mainly have no experience in developing new drugs, which has resulted in the fact that no new drug has appeared.

In contrast, Yang Rui, who worked on iron ketone in the past, has more experience in the development of new drugs.

If necessary, he can guide the researchers to develop new drugs without having to do it himself.

No matter how little the funds are, it is not impossible to develop new drugs with second-hand and low-end instruments.

It's nothing more than a longer time, the success rate is the first point.

If he doesn't want to waste the time of the researchers in the ion channel laboratory, Yang Rui can even hire temporary employees.

Hu Chi is now familiar with Yang Rui's speaking pattern, but he asked very vigilantly, "How poor is it?"

"It's a poor way." Yang Rui pondered for a moment, and said, "Sixty to seventy million dollars should be prepared. If it is less, it can reach 50 million dollars. If it is less, if you make two mistakes, you will be spared. At that time, it will be tantamount to wasting."

Yang Rui didn't mean to be alarmist either. Even if he could see the direction clearly, he didn't know how long the experiment would take.

Hu Chi pursed his lips and said, "Who can come up with fifty million at this time. It's still US dollars."

Yang Rui shrugged and said, "I'm going to go to the second phase of the clinical trial of iron ketone. If you are willing to hand over the latter part to foreign companies, you can do it at 30 million US dollars. This is the same as the Gaucher disease I am doing now. The cost of the drug is almost the same. Of course, it is possible that glucocerebrosidase cannot be produced for 30 million US dollars, but as long as the product is produced and shows promise, Zeneca should still be willing to increase the cost.”

"We don't have the money for additional costs."

"us?"

Hu Chi coughed twice, and said, "Mr. Li is also an old revolutionary back then. In short, 30 million US dollars is still too much."

"Then there is no way, this is the price of poverty."

"Can you talk to Zeneca? Let them join in and work together?" Hu Chi obviously did his homework. All he wanted was a new medicine. Although everyone didn't even talk about the new medicine, they always subconsciously thought that the new medicine would be good.

From this perspective, the introduction of foreign companies seems to have nothing to do with it. It not only saves the initial investment funds, but also obtains the desired medicines. The so-called market for technology is also.

However, medicines for common chronic diseases are not an easy field to conquer like rare diseases.

Even a multinational company like Zeneca has to be careful in this area. In history, there has been more than one case of investing 500 million U.S. dollars in costs and getting stuck in a quagmire.

Nobel laureates who fought in this field,

Not just one or two.

Yang Rui smiled and said, "You can try it with Jielikang. Before the glucocerebrosidase enzyme is on the market, it may be difficult for them to concentrate on a more complicated drug."

Hu Chi lost all momentum, and said: "You can't even talk about it, let alone us."

However, Hu Chi did not give up completely. After drinking two sips of tea, he said again: "The project you are working on now, don't you put it together a little bit? After two years, let Lao Li's family get you some more, not necessarily Suffer."

Yang Rui smiled and said, "Come on tomorrow and wait until you see the price of the equipment, so you don't say that."

He was talking about the upcoming procurement mission.

"Okay..." Hu Chi has no right to speak in the professional field, but based on his experience, foreigner's equipment is indeed outrageously expensive.

However, neither Yang Rui nor Hu Chi expected what kind of uproar would be caused after the news of the purchasing delegation spread.

It is not a trivial matter for the industry to organize a delegation for the Nobel Prize to go abroad for procurement.

Needless to say, even the central enterprises and large state-owned enterprises that had no plans at first have started to find relationships in a hurry.

When Yang Rui came home, he was stopped by several leaders of state-owned enterprises who went privately in micro-services as soon as he reached the alley.

It is very difficult to hide the address in the country, unless it is a small person who does not pay attention, otherwise, there will always be a day when it will be leaked.

Yang Rui held a banquet in the house, and he had expected it, but the officials in the past liked to stop at the door of the laboratory, and it was rare to stop at the door of the house.

"Director Yang."

"Professor Yang..."

Several leaders of state-owned enterprises greeted each other separately, but none of them belonged to the same group.

Yang Rui really wanted to slap a gavel and ask "what's the matter?".

"Professor Yang, I heard that you are going to organize a procurement delegation to go to Europe for procurement?" An official took the initiative to express his intentions. He stood too far behind, and the pleasantries were too far away.

Yang Rui nodded, and said: "There is such a thing, but it is not organized by me, it should be led by the Chemical Medicine Promotion Office or other organizations."

"No matter which department it is, you must have the final say." The official said a compliment with a smile, and said, "Professor Yang, our Siyou Company is a medical machinery production company directly under the Ministry. It’s time to update the production line, let’s see if I can join your delegation this time.”

"It's useless for you to find me..."

"You don't need the quota of the delegation, we just follow along, and you can give some suggestions when the time comes. Please, please." After finishing speaking, he stuffed a business card into Yang Rui's hand, and put another package of gifts on the ground. Just turn around and leave.

Others saw it, come on, let's do it, anyway, we don't have any friendship, so we can speak with sincerity.

In an instant, Yang Rui was surrounded by a ticket of gifts, and his hands were also full of business cards.

"Wait, wait." Yang Rui grabbed the smaller one and said, "What does it mean to follow along without a delegation?"

Seeing that Yang Rui really didn't know, the small-bodied leader said naturally: "There must be a small number of places in the delegation, and we don't expect to get them, so we will bring money to buy tickets and go with you. At that time, if you can Thank you very much for your pointers.”

Yang Rui pondered for a while before he realized that the quota of the delegation was mostly controlled by Hu Chi, and the activities organized by the Chemical Medicine Promotion Office were also paid by the Chemical Medicine Promotion Office, so naturally they took the lion's share.

If it is a large enterprise such as a central enterprise, the leaders probably went to public relations for Hu Chi, and those who came to Yang Rui wanted to make money.

It should be said that Chinese companies are also pitiful, not to mention the language barrier, and their understanding of the world trading system is pitiful, and they don't know much about professional knowledge.

In the era when many companies did not have college students to join the job, it is still very probable that the employees of the company can know the status of the latest equipment. Even through institutions such as the Institute of Foreign Affairs and Intelligence, it is difficult to get a comprehensive understanding.

Of course, in more cases, various research institutes simply don't bother to pay attention to such enterprises.

It is obviously an economical choice for them to act together with the Nobel laureates.

However, the size of this delegation is difficult to control.

Yang Rui can't even imagine how many companies in China have similar needs.